Stable pharmaceutical composition for treating osteoporosis
作者： Mondragón María Lourdes García , Santiago Alejandro Reyes
DOI:
关键词:
摘要: This invention provides pharmaceutical compositions which increase the bioavailability of risedronate sodium and vitamin D3 with greater stability; these are useful in inhibition bone resorption.
lens.org 参考文章(8)
Leon Shakib, Michael Fox, Formulations comprising vitamin d or derivatives thereof ,(2009)
David Ernest Burgio, Richard John Dansereau, Dosage forms of bisphosphonates ,(2005)
David Ernest Burgio, Richard John Dansereau, Dosage forms of risedronate ,(2005)
Jong Soo Woo, Hong Gi Yi, Ju Nam Jin, Complex formulation for preventing or treating osteoporosis which comprises solid dispersion of vitamin d or its derivative and bisphosphonate ,(2007)
Jin-Ha Park, Byong-Sun Choi, Jae-Shin Kim, Geun-Hyeog Lee, Eun-Mi Kim, Jin-Sun Kim, Mi-Jin O, Pharmaceutical compositions comprising bisphosphonate derivatives and high-dose cholecalciferol ,(2010)
Hyun Kyong Hwa, Choi Kyu Sang, Park Ho Seok, Kim Hye Jin, Bang Kyu Ho, Hwang Woo Sin, Hong Sa Yong, PHARMACEUTICAL COMPOSITION AND PREPARATION FOR TREATMENT OF METABOLIC BONE DISEASE COMPRISING RISEDRONATE AND VITAMIN D ,(2007)
Sid Mazel, Anastasia G Daifotis, Andrew Denker, Limin Zhu, John D Kirsch, Craig Ikeda, Randal Alan Seburg, Bogdan K Matuszewski, Arturo G Porras, Art Santora, John Yates, Compositions and methods for inhibiting bone resorption ,(2004)